Aurora Curatolo

Candiolo Cancer Institute

*This is an algorithmically generated author record based on publicly available information.

See Latest Publications

See Most Cited Publications

ORCID Profile

Google Scholar

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Candiolo Cancer Institute

Research Subjects

Research Interests

Aurora Curatolo has a total of 11 co-authors. Here are the top co-authors by number of shared publications:

Atsushi Kumanogoh
Department of Respiratory Medicine and Clinical Immunology, Graduate School of Medicine, The University of Osaka, Suita, Japan
30 shared publications
Carina Florina Cojocaru
Laboratory of Tumor Microenvironment, Candiolo Cancer Institute, FPO-IRCCS, 10060 Candiolo, Italy
30 shared publications
Emiko Mihara
Laboratory of Protein Synthesis and Expression, Institute for Protein Research, Osaka University, Osaka, Japan
30 shared publications
Enrico Giraudo
Laboratory of Tumor Microenvironment, Candiolo Cancer Institute, FPO-IRCCS, 10060 Candiolo, Italy
30 shared publications
Giulia Franzolin
Cancer Cell Biology Laboratory, Candiolo Cancer Institute-FPO, IRCCS, Candiolo, Italy
30 shared publications
Hiroaki Suga
Department of Chemistry, Graduate School of Science, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan
30 shared publications

Latest Publications

Sort by

Open Access
Website
Google Scholar
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S4 from PlexinB1 Inactivation Reprograms Immune Cells in the Tumor Microenvironment, Inhibiting Breast Cancer Growth and Metastatic Dissemination
by Giulia Franzolin, Serena Brundu, Carina F. Cojocaru, Aurora Curatolo, Matteo Ponzo, Roberta Mastrantonio, Emiko Mihara, Atsushi Kumanogoh, Hiroaki Suga, Junichi Takagi, et al.
Immune cell analysis of tumor draining lymph nodes of 4T1 WT and Plxnb1-/- mice
Website
Google Scholar
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open Access
Supplementary Figure S4 from PlexinB1 Inactivation Reprograms Immune Cells in the Tumor Microenvironment, Inhibiting Breast Cancer Growth and Metastatic Dissemination
by Giulia Franzolin, Serena Brundu, Carina F. Cojocaru, Aurora Curatolo, Matteo Ponzo, Roberta Mastrantonio, Emiko Mihara, Atsushi Kumanogoh, Hiroaki Suga, Junichi Takagi, et al.
Immune cell analysis of tumor draining lymph nodes of 4T1 WT and Plxnb1-/- mice
Open Access
Website
Google Scholar
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S2 from PlexinB1 Inactivation Reprograms Immune Cells in the Tumor Microenvironment, Inhibiting Breast Cancer Growth and Metastatic Dissemination
by Giulia Franzolin, Serena Brundu, Carina F. Cojocaru, Aurora Curatolo, Matteo Ponzo, Roberta Mastrantonio, Emiko Mihara, Atsushi Kumanogoh, Hiroaki Suga, Junichi Takagi, et al.
PLXNB1 depletion induces tumor vessel normalization and reduces tumor hypoxia
Website
Google Scholar
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open Access
Supplementary Figure S2 from PlexinB1 Inactivation Reprograms Immune Cells in the Tumor Microenvironment, Inhibiting Breast Cancer Growth and Metastatic Dissemination
by Giulia Franzolin, Serena Brundu, Carina F. Cojocaru, Aurora Curatolo, Matteo Ponzo, Roberta Mastrantonio, Emiko Mihara, Atsushi Kumanogoh, Hiroaki Suga, Junichi Takagi, et al.
PLXNB1 depletion induces tumor vessel normalization and reduces tumor hypoxia
Open Access
Website
Google Scholar
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S3 from PlexinB1 Inactivation Reprograms Immune Cells in the Tumor Microenvironment, Inhibiting Breast Cancer Growth and Metastatic Dissemination
by Giulia Franzolin, Serena Brundu, Carina F. Cojocaru, Aurora Curatolo, Matteo Ponzo, Roberta Mastrantonio, Emiko Mihara, Atsushi Kumanogoh, Hiroaki Suga, Junichi Takagi, et al.
PLXNB1 depletion induces higher number of infiltrating macrophages in 4T1 tumors and induces a shift toward M1 gene polarization in ex-vivo models.
Website
Google Scholar
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open Access
Supplementary Figure S3 from PlexinB1 Inactivation Reprograms Immune Cells in the Tumor Microenvironment, Inhibiting Breast Cancer Growth and Metastatic Dissemination
by Giulia Franzolin, Serena Brundu, Carina F. Cojocaru, Aurora Curatolo, Matteo Ponzo, Roberta Mastrantonio, Emiko Mihara, Atsushi Kumanogoh, Hiroaki Suga, Junichi Takagi, et al.
PLXNB1 depletion induces higher number of infiltrating macrophages in 4T1 tumors and induces a shift toward M1 gene polarization in ex-vivo models.
Open Access
Website
Google Scholar
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S5 from PlexinB1 Inactivation Reprograms Immune Cells in the Tumor Microenvironment, Inhibiting Breast Cancer Growth and Metastatic Dissemination
by Giulia Franzolin, Serena Brundu, Carina F. Cojocaru, Aurora Curatolo, Matteo Ponzo, Roberta Mastrantonio, Emiko Mihara, Atsushi Kumanogoh, Hiroaki Suga, Junichi Takagi, et al.
PLXNB1 depletion induces an activated phenotype in TILs and T-cells in vitro and enhances CD8+ T-cells recruitment in lung metastasis in 4T1 model
Website
Google Scholar
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open Access
Supplementary Figure S5 from PlexinB1 Inactivation Reprograms Immune Cells in the Tumor Microenvironment, Inhibiting Breast Cancer Growth and Metastatic Dissemination
by Giulia Franzolin, Serena Brundu, Carina F. Cojocaru, Aurora Curatolo, Matteo Ponzo, Roberta Mastrantonio, Emiko Mihara, Atsushi Kumanogoh, Hiroaki Suga, Junichi Takagi, et al.
PLXNB1 depletion induces an activated phenotype in TILs and T-cells in vitro and enhances CD8+ T-cells recruitment in lung metastasis in 4T1 model
Open Access
Website
Google Scholar
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S8 from PlexinB1 Inactivation Reprograms Immune Cells in the Tumor Microenvironment, Inhibiting Breast Cancer Growth and Metastatic Dissemination
by Giulia Franzolin, Serena Brundu, Carina F. Cojocaru, Aurora Curatolo, Matteo Ponzo, Roberta Mastrantonio, Emiko Mihara, Atsushi Kumanogoh, Hiroaki Suga, Junichi Takagi, et al.
PLXNB1 inhibition did not directly affect tumor cells both in vitro and in vivo in EMT6 TNBC mouse model
Website
Google Scholar
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open Access
Supplementary Figure S8 from PlexinB1 Inactivation Reprograms Immune Cells in the Tumor Microenvironment, Inhibiting Breast Cancer Growth and Metastatic Dissemination
by Giulia Franzolin, Serena Brundu, Carina F. Cojocaru, Aurora Curatolo, Matteo Ponzo, Roberta Mastrantonio, Emiko Mihara, Atsushi Kumanogoh, Hiroaki Suga, Junichi Takagi, et al.
PLXNB1 inhibition did not directly affect tumor cells both in vitro and in vivo in EMT6 TNBC mouse model
Open Access
Website
Google Scholar
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S7 from PlexinB1 Inactivation Reprograms Immune Cells in the Tumor Microenvironment, Inhibiting Breast Cancer Growth and Metastatic Dissemination
by Giulia Franzolin, Serena Brundu, Carina F. Cojocaru, Aurora Curatolo, Matteo Ponzo, Roberta Mastrantonio, Emiko Mihara, Atsushi Kumanogoh, Hiroaki Suga, Junichi Takagi, et al.
Pharmacological targeting of PLXNB1 does not impact on the hematological profile, nor on hepatic or renal functions and does not induce ADCC
Website
Google Scholar
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open Access
Supplementary Figure S7 from PlexinB1 Inactivation Reprograms Immune Cells in the Tumor Microenvironment, Inhibiting Breast Cancer Growth and Metastatic Dissemination
by Giulia Franzolin, Serena Brundu, Carina F. Cojocaru, Aurora Curatolo, Matteo Ponzo, Roberta Mastrantonio, Emiko Mihara, Atsushi Kumanogoh, Hiroaki Suga, Junichi Takagi, et al.
Pharmacological targeting of PLXNB1 does not impact on the hematological profile, nor on hepatic or renal functions and does not induce ADCC
Open Access
Website
Google Scholar
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S1 from PlexinB1 Inactivation Reprograms Immune Cells in the Tumor Microenvironment, Inhibiting Breast Cancer Growth and Metastatic Dissemination
by Giulia Franzolin, Serena Brundu, Carina F. Cojocaru, Aurora Curatolo, Matteo Ponzo, Roberta Mastrantonio, Emiko Mihara, Atsushi Kumanogoh, Hiroaki Suga, Junichi Takagi, et al.
Flow cytometry absolute cell counts
Website
Google Scholar
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open Access
Supplementary Table S1 from PlexinB1 Inactivation Reprograms Immune Cells in the Tumor Microenvironment, Inhibiting Breast Cancer Growth and Metastatic Dissemination
by Giulia Franzolin, Serena Brundu, Carina F. Cojocaru, Aurora Curatolo, Matteo Ponzo, Roberta Mastrantonio, Emiko Mihara, Atsushi Kumanogoh, Hiroaki Suga, Junichi Takagi, et al.
Flow cytometry absolute cell counts
Open Access
Website
Google Scholar
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S1 from PlexinB1 Inactivation Reprograms Immune Cells in the Tumor Microenvironment, Inhibiting Breast Cancer Growth and Metastatic Dissemination
by Giulia Franzolin, Serena Brundu, Carina F. Cojocaru, Aurora Curatolo, Matteo Ponzo, Roberta Mastrantonio, Emiko Mihara, Atsushi Kumanogoh, Hiroaki Suga, Junichi Takagi, et al.
PLXNB1 inhibition does not affect 4T1 cells extravasation to the lung and their ability to adhere to endothelial cells
Website
Google Scholar
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open Access
Supplementary Figure S1 from PlexinB1 Inactivation Reprograms Immune Cells in the Tumor Microenvironment, Inhibiting Breast Cancer Growth and Metastatic Dissemination
by Giulia Franzolin, Serena Brundu, Carina F. Cojocaru, Aurora Curatolo, Matteo Ponzo, Roberta Mastrantonio, Emiko Mihara, Atsushi Kumanogoh, Hiroaki Suga, Junichi Takagi, et al.
PLXNB1 inhibition does not affect 4T1 cells extravasation to the lung and their ability to adhere to endothelial cells
Open Access
Website
Google Scholar
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S6 from PlexinB1 Inactivation Reprograms Immune Cells in the Tumor Microenvironment, Inhibiting Breast Cancer Growth and Metastatic Dissemination
by Giulia Franzolin, Serena Brundu, Carina F. Cojocaru, Aurora Curatolo, Matteo Ponzo, Roberta Mastrantonio, Emiko Mihara, Atsushi Kumanogoh, Hiroaki Suga, Junichi Takagi, et al.
The treatment with Fc(m6A9)B3 PLXNB1 inhibitor decreases M2-like macrophages and enhances the number of CD8+ GrzB+ T-cells in Py230 model
Website
Google Scholar
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open Access
Supplementary Figure S6 from PlexinB1 Inactivation Reprograms Immune Cells in the Tumor Microenvironment, Inhibiting Breast Cancer Growth and Metastatic Dissemination
by Giulia Franzolin, Serena Brundu, Carina F. Cojocaru, Aurora Curatolo, Matteo Ponzo, Roberta Mastrantonio, Emiko Mihara, Atsushi Kumanogoh, Hiroaki Suga, Junichi Takagi, et al.
The treatment with Fc(m6A9)B3 PLXNB1 inhibitor decreases M2-like macrophages and enhances the number of CD8+ GrzB+ T-cells in Py230 model
Open Access
Website
Google Scholar
- 3 September 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S5 from PlexinB1 Inactivation Reprograms Immune Cells in the Tumor Microenvironment, Inhibiting Breast Cancer Growth and Metastatic Dissemination
by Giulia Franzolin, Serena Brundu, Carina F. Cojocaru, Aurora Curatolo, Matteo Ponzo, Roberta Mastrantonio, Emiko Mihara, Atsushi Kumanogoh, Hiroaki Suga, Junichi Takagi, et al.
PLXNB1 depletion induces an activated phenotype in TILs and T-cells in vitro and enhances CD8+ T-cells recruitment in lung metastasis in 4T1 model
Website
Google Scholar
- 3 September 2024
- Published by American Association for Cancer Research (AACR)
Open Access
Supplementary Figure S5 from PlexinB1 Inactivation Reprograms Immune Cells in the Tumor Microenvironment, Inhibiting Breast Cancer Growth and Metastatic Dissemination
by Giulia Franzolin, Serena Brundu, Carina F. Cojocaru, Aurora Curatolo, Matteo Ponzo, Roberta Mastrantonio, Emiko Mihara, Atsushi Kumanogoh, Hiroaki Suga, Junichi Takagi, et al.
PLXNB1 depletion induces an activated phenotype in TILs and T-cells in vitro and enhances CD8+ T-cells recruitment in lung metastasis in 4T1 model

Show all